TALPHERA, INC. Cost of Revenue
TALPHERA, INC. (TLPH) reported Cost of Revenue of $0 for the 12-month period ending 2022-12-31, per its 8-K filed 2023-08-01.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2023-08-01
- TALPHERA, INC. cost of goods and services sold for the quarter ending 2022-12-31 was -$2.23M.
- TALPHERA, INC. cost of goods and services sold for the quarter ending 2022-09-30 was $569.00K, a 29.61% increase year-over-year.
- TALPHERA, INC. cost of goods and services sold for the quarter ending 2022-06-30 was $876.00K, a 15.77% decline year-over-year.
- TALPHERA, INC. cost of goods and services sold for the quarter ending 2022-03-31 was $784.00K, a 24.62% decline year-over-year.
- TALPHERA, INC. cost of goods and services sold for fiscal 2020 was $6.03M, a 11.37% decline from fiscal 2019.
- TALPHERA, INC. cost of goods and services sold for fiscal 2019 was $6.81M, a 71.18% increase from fiscal 2018.
- TALPHERA, INC. cost of goods and services sold for fiscal 2018 was $3.98M, a 62.70% decline from fiscal 2017.
- TALPHERA, INC. cost of goods and services sold for fiscal 2017 was $10.66M, a 13.45% decline from fiscal 2016.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | -$2.23M derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | -$1.66M derived: sum of 2 quarters · filed 2023-08-01 | -$784.00K derived: sum of 3 quarters · filed 2023-08-01 | $0.00 8-K · filed 2023-08-01 | $2.59M 10-K · filed 2023-03-31 |
| 2022-09-30 | $569.00K 10-Q · filed 2022-11-14 | $1.45M derived: sum of 2 quarters · filed 2022-11-14 | $2.23M 10-Q · filed 2022-11-14 | $281.00K derived: sum of 4 quarters · filed 2023-08-01 | |
| 2022-06-30 | $876.00K 10-Q · filed 2022-08-11 | $1.66M 10-Q · filed 2022-08-11 | -$288.00K derived: sum of 3 quarters · filed 2023-08-01 | $151.00K derived: sum of 4 quarters · filed 2023-08-01 | |
| 2022-03-31 | $784.00K 10-Q · filed 2022-05-16 | -$1.16M derived: sum of 2 quarters · filed 2023-08-01 | -$725.00K derived: sum of 3 quarters · filed 2023-08-01 | $315.00K derived: sum of 4 quarters · filed 2023-08-01 | |
| 2021-12-31 | -$1.95M derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | -$1.51M derived: sum of 2 quarters · filed 2023-08-01 | -$469.00K derived: sum of 3 quarters · filed 2023-08-01 | $571.00K 8-K · filed 2023-08-01 | $3.75M 10-K · filed 2022-03-10 |
| 2021-09-30 | $439.00K 10-Q · filed 2022-11-14 | $1.48M derived: sum of 2 quarters · filed 2022-11-14 | $2.52M 10-Q · filed 2022-11-14 | $3.82M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $1.04M 10-Q · filed 2022-08-11 | $2.08M 10-Q · filed 2022-08-11 | $3.38M derived: sum of 3 quarters · filed 2022-08-11 | $5.23M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $1.04M 10-Q · filed 2022-05-16 | $2.34M derived: sum of 2 quarters · filed 2022-05-16 | $4.19M derived: sum of 3 quarters · filed 2022-05-16 | $5.56M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $3.15M derived: sum of 2 quarters · filed 2022-03-10 | $4.52M derived: sum of 3 quarters · filed 2022-03-10 | $6.03M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $1.85M 10-Q · filed 2021-11-15 | $3.22M derived: sum of 2 quarters · filed 2021-11-15 | $4.73M 10-Q · filed 2021-11-15 | $6.35M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $1.37M 10-Q · filed 2021-08-16 | $2.88M 10-Q · filed 2021-08-16 | $4.50M derived: sum of 3 quarters · filed 2021-08-16 | $6.65M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $1.51M 10-Q · filed 2021-05-17 | $3.13M derived: sum of 2 quarters · filed 2021-05-17 | $5.28M derived: sum of 3 quarters · filed 2021-05-17 | $7.09M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $3.77M derived: sum of 2 quarters · filed 2021-03-15 | $5.58M derived: sum of 3 quarters · filed 2021-03-15 | $6.81M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $2.15M 10-Q · filed 2020-11-05 | $3.96M derived: sum of 2 quarters · filed 2020-11-05 | $5.19M 10-Q · filed 2020-11-05 | $6.43M derived: sum of 4 quarters · filed 2021-03-15 | |
| 2019-06-30 | $1.81M 10-Q · filed 2020-08-10 | $3.04M 10-Q · filed 2020-08-10 | $4.28M derived: sum of 3 quarters · filed 2021-03-15 | $5.15M derived: sum of 4 quarters · filed 2021-03-15 | |
| 2019-03-31 | $1.23M 10-Q · filed 2020-05-11 | $2.47M derived: sum of 2 quarters · filed 2021-03-15 | $3.34M derived: sum of 3 quarters · filed 2021-03-15 | $4.09M derived: sum of 4 quarters · filed 2021-03-15 | |
| 2018-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $2.11M derived: sum of 2 quarters · filed 2021-03-15 | $2.86M derived: sum of 3 quarters · filed 2021-03-15 | $3.98M 10-K · filed 2021-03-15 | |
| 2018-09-30 | $875.00K 10-Q · filed 2019-11-07 | $1.62M derived: sum of 2 quarters · filed 2019-11-07 | $2.74M 10-Q · filed 2019-11-07 | $3.70M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-06-30 | $749.00K 10-Q · filed 2019-08-06 | $1.86M 10-Q · filed 2019-08-06 | $2.83M derived: sum of 3 quarters · filed 2020-03-16 | $4.85M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-03-31 | $1.11M 10-Q · filed 2019-05-09 | $2.08M derived: sum of 2 quarters · filed 2020-03-16 | $4.11M derived: sum of 3 quarters · filed 2020-03-16 | $7.65M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2017-12-31 | $962.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $2.99M derived: sum of 2 quarters · filed 2020-03-16 | $6.53M derived: sum of 3 quarters · filed 2020-03-16 | $10.66M 10-K · filed 2020-03-16 | |
| 2017-09-30 | $2.03M 10-Q · filed 2018-11-05 | $5.57M derived: sum of 2 quarters · filed 2018-11-05 | $9.70M 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | $3.54M 10-Q · filed 2018-08-02 | $7.67M 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | $4.13M 10-Q · filed 2018-05-10 | ||||
| 2016-12-31 | $12.31M 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |